Evidence map›Paper›PMID 23595572›Full record

ArticleInternational urology and nephrology2013

MTHFR, MTR and MTRR polymorphisms and risk of chronic kidney disease in Japanese: cross-sectional data from the J-MICC Study.

Asahi Hishida, Rieko Okada, Yin Guang, Mariko Naito, Kenji Wakai, Satoyo Hosono, Kazuyo Nakamura, Tanvir Chowdhury Turin, Sadao Suzuki, Hideshi Niimura and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 3 countries.

Asahi HishidaDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan, a-hishi@med.nagoya-u.ac.jp.
Rieko Okada
Yin Guang
Mariko Naito
Kenji Wakai
Satoyo Hosono
Kazuyo Nakamura
Tanvir Chowdhury Turin
Sadao Suzuki
Hideshi Niimura
Haruo Mikami
Jun Otonari
Nagato Kuriyama
Sakurako Katsuura
Michiaki Kubo
Hideo Tanaka
Nobuyuki Hamajima
Nagoya University · JPAichi Cancer Center · JPChiba Cancer Center · JPKagoshima University · JPKyoto Prefectural University of Medicine · JPKyushu University · JPNagoya City University · JPRIKEN · JPSaint Mary's College of California · USShiga University of Medical Science · JPTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChronic kidney disease (CKD) is well known as a strong risk factor for both of end-stage renal disease and cardiovascular disease. To clarify the associations of MTHFR, MTR, and MTRR polymorphisms with the risk of CKD in Japanese, we examined this association among Japanese subjects using cross-sectional data.

methodsThe subjects for this analysis were 3,318 participants consecutively selected from the Japan Multi-institutional Collaborative Cohort (J-MICC) Study. The polymorphisms were genotyped by a multiplex polymerase chain reaction-based Invader assay. Age- and sex-adjusted odds ratio (aOR) of CKD with stage 3-5 was calculated for each genotype.

resultsWhen those with MTHFR C677T C/C were defined as references, those with MTHFR C677T C/T and T/T demonstrated the aORs for CKD of 1.14 (95 % CI 0.93-1.40) and 1.39 (1.06-1.82), respectively. Marginally significantly decreased risk of CKD with increasing number of MTR A2756G G allele (p = 0.058) was observed. Stratified analyses by plasma folate low (<7.4 ng/ml) or high (≥7.4 ng/ml) suggested significantly higher OR of CKD for those with MTHFR C677T T/T and low serum folate with the aOR of 2.07 (95 % CI 1.30-3.31) compared with that for those with MTHFR C677T T/T and high serum folate.

conclusionsThe present study found a significant association between the subjects with the T/T genotype of MTHFR C677T polymorphism and the elevated risk of CKD, which may suggest the possibility of the risk evaluation and prevention of this potentially life-threatening disease based on genetic traits in the near future.

Indexed as

5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseAgedAlcohol DrinkingAsian PeopleCreatinineCross-Sectional StudiesDietFerredoxin-NADP ReductaseFolic AcidGene FrequencyGenotypeHumansJapanMethylenetetrahydrofolate Reductase (NADPH2)Middle AgedPolymorphism, Genetic5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseCreatinineFerredoxin-NADP ReductaseFolic Acidmethionine synthase reductaseMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanMTR protein, human

Identifiers

PMID23595572
OpenAlexW1976800149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.